Jayati Mondal

This study investigates how N361 glycosylation affects EGFR function, finding that the N361A mutation reduces proliferation and ligand sensitivity while increasing co-localization with HER2 and resistance to antibody inhibition.

This study develops PNA oligomers targeting KRAS G12D mutations with cell-penetrating peptides, showing selective repression of mutant mRNA and protein in cells and efficacy in vivo.